FDA Approves Elekta’s Latest Generation Intracranial Radiosurgery System

by Vishnuprasad on  August 8, 2015 at 2:11 PM Medical Gadgets
RSS Email Print This Page Comment
The US Food and Drug Administration (FDA) has approved Elekta's Leksell Gamma Knife Icon radiosurgery system.

Elekta is a Swedish company that provides radiation therapy, radiosurgery, related equipment and clinical management for the treatment of cancer and brain disorders.
FDA Approves Elekta’s Latest Generation Intracranial Radiosurgery System
FDA Approves Elekta’s Latest Generation Intracranial Radiosurgery System
Advertisement

With stereotactic imaging, online Adaptive DoseControl - a comprehensive concept that confirms accuracy and ensures precision of treatment delivery, ultra-precise dose delivery and the availability of frameless treatments, Icon is capable of treating virtually any target in the brain, regardless of type, location or volume.

Advertisement
The Icon represents the sixth generation of the company's Leksell Gamma Knife system, a technology that has been in use and continually evolving since the 1980s.

Gamma Knife radiosurgery is a gentler alternative to traditional brain surgery for illnesses such as metastatic disease.

The company claims that the system delivers up to thousands of low-intensity radiation beams to one or more targets in a single session with pinpoint accuracy.

Bill Yaeger, the company's Executive Vice President region North America, noted that Leksell Gamma Knife Icon offers a new model for the application of precise radiosurgery for a virtually unlimited range of cranial cases.

"Physicians have the flexibility to employ either frame-based or frameless techniques to immobilize the patient's head, in addition to the option to treat the patient in one session or multiple sessions. Importantly, Icon is the only system with the accuracy to enable ultra-precise Microradiosurgery in cases that demand the utmost precision," Yaeger added.



Source: Medindia
Advertisement

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
Notify me when reply is posted
I agree to the terms and conditions
Advertisement

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Advertisement

Advertisement
Advertisement

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook

News Category

News Archive